Takara Bio Inc. announced unaudited consolidated earnings results for the six months ended September 30, 2018. For the period, net sales were JPY 17,370 million compared to JPY 14,126 million a year ago. Operating income was JPY 2,623 million compared to JPY 688 million a year ago. Income before income taxes and minority interests was JPY 2,436 million against JPY 749 million a year ago. Net income was 1,717 million against JPY 299 million a year ago. Net income per share was JPY 14.29 compared to JPY 2.51 per share a year ago.

The company also provided the earnings forecast for the year ending March 31, 2019. For the year, the company expecting a net sales of JPY 35,800 million, Operating income of 5,000 million, net income attributable to owner of parent of JPY 3,100 million and net income attributable to owner of parent per share of JPY 25.74.